Literature DB >> 2499095

Increased expression of HLA-DR antigen on alveolar macrophages in pulmonary diseases.

W Popp1, O Braun, H Zwick, H Rauscher, L Ritschka.   

Abstract

The expression of HLA-DR antigen on alveolar macrophages obtained by bronchoalveolar lavage in healthy controls and patients with different diseases was investigated, using cytofluorographic analysis and phykoerythrin conjugated monoclonal mouse anti-human HLA-DR antibody. Alveolar macrophages in patients with extrinsic allergic alveolitis (n = 4), idiopathic lung fibrosis (n = 4), sarcoidosis (n = 6), rheumatoid lung disease (n = 6) and pulmonary infection (n = 5) showed increased density of HLA-DR antigen expression compared to healthy control subjects (n = 5). The increased expression of HLA-DR antigen on alveolar macrophages confirms the importance of these cells for recognition of antigens and immunological responses in different pulmonary diseases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2499095     DOI: 10.1007/bf00718622

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  16 in total

1.  Quantitative variation in la antigen expression plays a central role in immune regulation.

Authors:  C A Janeway; K Bottomly; J Babich; P Conrad; S Conzen; B Jones; J Kaye; M Katz; L McVay; D B Murphy; J Tite
Journal:  Immunol Today       Date:  1984-04

2.  Human alveolar macrophage regulation of lymphocyte proliferation.

Authors:  D B Ettensohn; P A Lalor; N J Roberts
Journal:  Am Rev Respir Dis       Date:  1986-06

3.  [Immunocytologic and immunohistochemical methods of detection in exogenous allergic alveolitis].

Authors:  W Popp; O Braun; H Zwick; L Ritschka; H Rauscher
Journal:  Prax Klin Pneumol       Date:  1988-07

4.  Bronchoalveolar lavage. The report of an international conference.

Authors:  R G Crystal; H Y Reynolds; A R Kalica
Journal:  Chest       Date:  1986-07       Impact factor: 9.410

Review 5.  Role of MHC gene products in immune regulation.

Authors:  B Benacerraf
Journal:  Science       Date:  1981-06-12       Impact factor: 47.728

6.  Immunologic functions of Ia-bearing epidermal Langerhans cells.

Authors:  G Stingl; S I Katz; L Clement; I Green; E M Shevach
Journal:  J Immunol       Date:  1978-11       Impact factor: 5.422

7.  Antigen presentation: comments on its regulation and mechanism.

Authors:  E R Unanue; D I Beller; C Y Lu; P M Allen
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

Review 8.  Antigen presenting cells in situ: their identification and involvement in immunopathology.

Authors:  L W Poulter
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

9.  Expression of Ia-like (DR) antigen on human alveolar macrophages isolated by bronchoalveolar lavage.

Authors:  A G Razma; J P Lynch; B S Wilson; P A Ward; S L Kunkel
Journal:  Am Rev Respir Dis       Date:  1984-03

10.  The human alveolar macrophage: isolation, cultivation in vitro, and studies of morphologic and functional characteristics.

Authors:  A B Cohen; M J Cline
Journal:  J Clin Invest       Date:  1971-07       Impact factor: 14.808

View more
  4 in total

1.  Bronchoalveolar lavage in rheumatoid arthritis and secondary Sjögren's syndrome.

Authors:  W Popp; L Ritschka; O Scherak; O Braun; G Kolarz; H Rauscher; H Zwick
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Delineation of pulmonary alveolar macrophage subpopulations by flow cytometry in normal subjects and in patients with lung cancer.

Authors:  C F McDonald; P Hutchinson; R C Atkins
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

3.  Correlation of morphological patterns of nucleoli in alveolar macrophages with HLA-DR antigen expression in sarcoidosis.

Authors:  W Popp; F J Wachtler
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

4.  Blood monocytes of untreated asthmatics exhibit some features of tissue macrophages.

Authors:  A Rivier; J Pène; H Rabesandratana; P Chanez; J Bousquet; A M Campbell
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.